Nantahala Capital Management, LLC

Position in TNGX — Tango Therapeutics, Inc.

CIK 1472322 New Canaan, CT

Position in TNGX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$26,159,455

-$5,494,073 QoQ

Shares Held

1,250,452

-65.0% QoQ

Ownership

0.864%

of shares outstanding

% of Portfolio

1.64%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Nantahala Capital Management, LLC holds $574,927,961 across 52 Biotechnology names. TNGX ranks #3 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SLNO	Soleno Therapeutics Inc	1,744,124	$58,393,271
2	SVRA	Savara Inc	7,344,783	$40,102,515
3	TNGX	Tango Therapeutics, Inc. This page	1,250,452	$26,159,455
4	LBRX	Lb Pharmaceuticals Inc	1,052,894	$25,964,366
5	MLYS	Mineralys Therapeutics, Inc.	895,481	$24,258,580
6	ZVRA	Zevra Therapeutics, Inc.	2,521,936	$23,504,443
7	FULC	Fulcrum Therapeutics, Inc.	3,050,040	$23,393,806
8	ABEO	Abeona Therapeutics Inc.	5,013,052	$22,458,472

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$26,159,455	1,250,452	-65.0%	Shares	Sole	2026-05-15
2025-12-31	$31,653,528	3,572,633	+97.4%	Shares	Sole	2026-02-13
2025-09-30	$15,203,563	1,809,948	-47.4%	Shares	Sole	2025-11-14
2025-06-30	$17,610,721	3,439,594	+15.1%	Shares	Sole	2025-08-14
2025-03-31	$4,093,536	2,987,983	+6.5%	Shares	Sole	2025-05-15
2024-12-31	$8,665,626	2,804,410	+2738.6%	Shares	Sole	2025-02-14
2022-03-31	$748,858	98,794	-1.2%	Shares	Sole	2022-05-13
2021-12-31	$1,094,000	100,000	0.0%	Shares	Sole	2022-02-14
2021-09-30	$1,293,000	100,000	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.